Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.45, $0.18 better than the analyst estimate of $0.27. Revenue for the quarter came in at $290.56 million versus the consensus estimate of $275.28 million.

GUIDANCE:

Omnicell sees Q3 2025 EPS of $0.30-$0.37, versus the consensus of $0.37. Omnicell sees Q3 2025 revenue of $290-300 million, versus the consensus of $284.1 million.

Omnicell sees FY2025 EPS of $1.40-$1.65, versus the consensus of $1.37. Omnicell sees FY2025 revenue of $1.13-1.16 billion, versus the consensus of $1.18 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.